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Research
Acute exposure to ozone causes transient
respiratory symptoms, reversible decrements
in pulmonary function, and an inﬂammatory
response that may persist for at least 18–24 hr
after exposure. A thorough review of recent
epidemiologic and controlled human expo-
sure studies is available elsewhere [U.S.
Environmental Protection Agency (EPA)
2006]. Controlled exposures of healthy young
adults show that the magnitude of these respi-
ratory effects is a function of O3 concentra-
tion, minute ventilation (VE), and exposure
duration. The primary focus of this article is
the effect of short-term controlled O3 expo-
sures on forced expiratory volume in 1 sec
(FEV1) as a measure of lung function in
healthy young adults. Because small changes
in spirometry in healthy young adults may
result from exercise, diurnal, or other effects in
addition to the effects of O3 during the course
of an exposure, we use the term “O3-induced”
here to designate effects that we have cor-
rected for such extraneous responses as meas-
ured during ﬁltered air (FA) exposures.
After prolonged, 6.6-hr exposures to O3 at
concentrations of ≥ 0.08 ppm, young healthy
adults develop signiﬁcant reversible decrements
in FEV1 at a moderate level of exercise (VE =
40 L/min). Exposures to 0.04-ppm O3 result in
small, statistically nonsigniﬁcant O3-induced
responses (Adams 2002). Volunteers exposed
to 0.08 ppm O3 experience group mean O3-
induced FEV1 decrements that range from 6%
to 8% (Adams 2003, 2006; Horstman et al.
1990; McDonnell et al. 1991); those exposed
to 0.10 ppm have group mean decrements of
8–14% (Horstman et al. 1990; McDonnell
et al. 1991); and those exposed to 0.12 ppm
have group mean decrements of 13–16%
(Adams 2002; Folinsbee et al. 1988; Horstman
et al. 1990). The distribution of individual
responses becomes skewed with increasing
exposure concentration and magnitude of the
group mean FEV1 response (McDonnell
1996). Taken together, these data indicate that
FEV1 responses are clearly affected by 6.6-hr
exposures to O3 concentrations ≥ 0.08 ppm.
These data also suggest that smaller, but mea-
surable, responses are likely to occur with 6.6-
hr exposure to concentrations somewhat below
0.08 ppm. We are particularly interested in
estimating the magnitude of FEV1 responses to
concentrations < 0.08 ppm, with the ultimate
goals of better characterizing the concentra-
tion–response (C–R) relationship and reducing
uncertainty in the assessment of risk at low O3
concentrations.
Until recently, published data have not
been available for 6.6-hr exposures to O3
concentrations between 0.04 and 0.08 ppm.
Adams (2006) provided results for healthy
young individuals (15 males, 15 females) ran-
domly exposed for 6.6 hr on six separate
occasions to FA, to constant or square-wave
(S-W) 0.06 ppm and 0.08 ppm O3, and to
three variable concentration patterns having
mean overall exposure O3 concentrations of
0.04, 0.06, and 0.08 ppm. The subjects
(mean age ~ 23 years) were recruited from the
University of California, Davis, and the sur-
rounding community. Measures of FEV1
were conducted before exposure and after
approximately 1, 2, 3, 4.6, 5.6, and 6.6 hr of
exposure. Each 6.6-hr exposure was con-
ducted in an exposure chamber and included
six 1-hr periods in which participants alter-
nated 50 min of exercise with 10 min of rest.
An additional 35-min rest/lunch period in
the chamber followed the third hour of expo-
sure. Exercise was calibrated to generate a VE
of approximately 20 L/min/m2 body surface
area (BSA) for each volunteer. There was a
minimum of 4 days between exposures.
Additional details related to volunteer charac-
teristics, study design, facilities, measurement
methods, exposure characterization, and
results are available from Adams (2006). 
The stated purpose of the Adams (2006)
study was to compare the responses to the
0.08-ppm S-W exposure with the responses
to the other five exposure conditions.
Comparisons of responses among the other
ﬁve exposure conditions (e.g., the 0.06-ppm
S-W exposure with the FA exposure) at vari-
ous time points were also presented. After the
detection of statistically significant effects
within the data using a two-way analysis of
variance technique, the Scheffé multiple com-
parison test was used to identify which spe-
ciﬁc comparisons were signiﬁcantly different.
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BACKGROUND: Ozone is a potent photochemical oxidant that produces transient, reversible decre-
ments in the lung function of acutely exposed individuals. A recent study provided previously
unavailable clinical data for 30 healthy young adults exposed to O3 at 0.06 ppm. That study
showed significant effects of 0.08 ppm on lung function, confirming the findings of others.
However, exposure to 0.06 ppm O3 was not reported to signiﬁcantly affect lung function.
OBJECTIVES: We conducted this analysis to reevaluate the existing lung function data of the volun-
teers previously exposed to 0.06 ppm O3.
METHODS: We obtained pre- and postexposure data on forced expiratory volume in 1 sec (FEV1)
for all subjects who were previously exposed for 6.6 hr to ﬁltered air or to 0.06 ppm or 0.08 ppm
O3. We used standard statistical methods appropriate for paired comparisons to reanalyze FEV1
responses after exposure to 0.06 ppm O3 relative to ﬁltered air.
RESULTS: Controlling for ﬁltered air responses, 24 of the 30 subjects experienced an O3-induced
decrement in FEV1. On average, 0.06 ppm O3 exposure caused a 2.85% reduction in FEV1 (p <
0.002), which was consistent with the predicted FEV1 response from existing models. Although the
average response was small, two subjects had > 10% FEV1 decrements.
CONCLUSIONS: Exposure to 0.06 ppm O3 causes a biologically small but highly statistically signiﬁ-
cant decrease in mean FEV1 responses of young healthy adults.
KEY WORDS: air pollutants, photochemical oxidants, spirometry. Environ Health Perspect
116:1023–1026 (2008). doi:10.1289/ehp.11396 available via http://dx.doi.org/ [Online 21 April 2008]None of the differences between the FEV1
responses of exposure to 0.06 ppm O3 and
FA were identified as statistically different
from zero. However, Figure 1, which we
adapted from Adams (2006), shows that
the response to 0.06-ppm O3 exposure
diverges over time from the response to FA.
Additionally, the lack of overlap of the SE
bars at the 6.6-hr time point suggests that the
postexposure differences between FA and
0.06 ppm O3 are not likely to be attributed to
chance alone.
Although the Scheffé method for detecting
speciﬁc differences in the context of correcting
for all possible contrasts in the data avoids type
1 statistical errors (false positives) at the level of
the overall study, it is characterized as having
relatively low power for detecting small differ-
ences for any single comparison of interest and
is recognized as being a conservative test
(Schwertman and Carter 1995). In the absence
of calculations of statistical power or the proba-
bility of making a type 2 statistical error for the
comparison between the postexposure
responses of the FA and 0.06-ppm O3 expo-
sures, we interpret the reported results of the
Adams analysis as being inconclusive regarding
the existence of an effect of 0.06-ppm O3
exposure on FEV1 response. That is, the inabil-
ity to reject the null hypothesis of no difference
between two conditions is not sufficient to
conclude that no such difference exists.
Because of the potential regulatory impli-
cations of the presence or absence of effects at
concentrations below the level of the current
National Ambient Air Quality Standard
(NAAQS) for O3 (currently 0.075 ppm)
(NAAQS 2008), we elected to further exam-
ine the responses to 0.06 ppm O3 docu-
mented in the Adams (2006) study. Because
the U.S. EPA risk assessment for lung func-
tion effects and the current NAAQS for O3
are generally based on the postexposure
responses of a group of published 6.6-hr S-W
studies, we conducted a targeted, secondary
analysis of the Adams data to focus on the
specific question of whether exposure to
0.06 ppm O3 for 6.6 hr results in FEV1
decrements relative to the FA exposure.
Materials and Methods
The data presented here were originally
collected for a recent study of humans exposed
to low levels of O3 (Adams 2006). The expo-
sures of interest for the purpose of the analysis
presented here are the constant-concentration
or S-W exposures to 0.06 ppm O3 and to FA.
For purposes of comparison with other studies,
we also present some results from the 0.08-ppm
S-W O3 exposures from the Adams (2006)
study. Although only group statistics were pre-
sented in the Adams (2006) publication, each
subject’s FEV1 measurement before and after
the 6.6-hr exposures was made available by the
author to the U.S. EPA for inclusion in its Air
Quality Criteria Document for O3 and Related
Photochemical Oxidants (U.S. EPA 2006) and
its health risk assessment (U.S. EPA 2007). We
analyzed these individual pre- and postexposure
FEV1 data.
The question of interest here is whether a
6.6-hr exposure to 0.06 ppm O3 under the
conditions of the Adams (2006) study results
in postexposure FEV1 decrements greater than
those after a control exposure to FA. We calcu-
lated the FEV1 percent decrement for FA and
for 0.06-ppm O3 exposures for each of the 30
participants as 100% × (preexposure FEV1 –
postexposure FEV1)/preexposure FEV1. We
then calculated the FEV1 response due to O3
(i.e., O3-induced) by subtracting the percent
decrement after FA from the percent decre-
ment after 0.06 ppm O3 for each volunteer.
The distribution of O3-induced responses in
these data did not appear to deviate markedly
from a Gaussian distribution. However, it is
well known that higher-dose O3 exposures that
produce larger group mean FEV1 responses
result in frequency distributions of response
that are quite skewed, thereby potentially chal-
lenging some of the assumptions of many para-
metric statistical tests (Kulle et al. 1985;
McDonnell 1996; Weinmann et al. 1995).
The nonparametric sign test, which assumes
only that the responses of each subject are
independent and makes no assumptions about
the distribution of the response data, is appro-
priate to test the null hypothesis that observed
values have the same probability of being posi-
tive or negative (Fisher and Belle 1993). We
therefore selected the sign test as our primary
test of the null hypothesis that the FEV1
responses for the FA and 0.06-ppm exposures
are not different.
Because the individual O3-induced decre-
ments in this study were generally symmetrical
and because other studies have demonstrated
that exposures that produce mean responses of
the magnitude observed in this study result in
roughly symmetric response distributions
(Kulle et al. 1985; McDonnell et al. 1983), we
also compared the FA and 0.06-ppm O3
responses using other methods. We used the
Wilcoxon signed rank test, which makes the
assumption that the individual O3-induced
responses are symmetrically distributed, and
the paired t-test, which makes the further
assumption that the responses are normally
distributed (Fisher and Belle 1993).
We calculated two-sided statistical tests
using SYSTAT 5.0 (Systat, Inc., Evanston, IL),
and we examined Tukey box plots to assess
potential outlier data using Graph Pad Prism 5
(Graph Pad Software, Inc., San Diego, CA).
Results
Table 1 lists the individual percentage
decrements in FEV1 from baseline after the
FA and 0.06-ppm O3 exposures and the O3-
induced decrements. For the full data set (n =
30), the O3-induced FEV1 responses appear
to be symmetrically distributed around the
median of 2.91% and mean of 2.85%.
Twenty-four of the 30 individuals experi-
enced an O3-induced decrement greater than
zero (range, 0.23–14.52%), whereas six expe-
rienced an improvement in FEV1 (range,
–0.43% to –7.42%) after the exposure. The
Brown et al.
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Table 1. Percent decrement in FEV1 for 6.6 hr of
exposure to FA and 0.06 ppm O3 for individuals in
the Adams (2006) study. 
Subject ΔFA ΔO3 ΔO3 – ΔFA
1 –1.46 –0.87 0.59
2 0.20 3.01 2.81
3 –0.29 5.93 6.23
4 –5.33 –3.52 1.81
5 –8.62 –3.75 4.87
6 –2.94 –3.89 –0.95
7 –0.21 0.21 0.42
8 –0.28 3.43 3.71
9 –3.12 3.91 7.03
10 –6.32 6.43 12.76a
11 –0.53 0.53 1.07
12 4.76 –2.66 –7.42a
13 –1.71 –2.87 –1.16
14 –0.42 2.87 3.29
15 –1.16 –0.57 0.58
16 –5.54 –1.74 3.80
17 –0.62 –1.05 –0.43
18 –4.35 1.88 6.23
19 –3.17 1.98 5.15
20 2.02 5.03 3.00
21 –2.19 3.66 5.85
22 –2.19 –5.13 –2.93
23 0.21 14.73 14.52a
24 –0.58 0.59 1.17
25 –0.27 0.54 0.81
26 –4.14 1.10 5.24
27 1.79 2.02 0.23
28 0.19 –0.40 –0.60
29 0.87 4.21 3.34
30 5.02 9.62 4.60
Mean –1.35 1.51 2.85
SD 2.98 4.24 4.28
ΔO3 – ΔFA represents the decrements due to 0.06 ppm O3
corrected for any FA effects. Data are FEV1 percent decre-
ments from preexposure; a negative number indicates an
increase or improvement in FEV1.
aPotential outlier according to the Tukey criteria.
Figure 1. Mean FEV1 decrements as function of
exposure duration and O3 concentration. Data are
for constant, S-W O3 protocols in the Adams (2006)
study. Error bars are the SE of responses at 6.6 hr.
Adapted from Adams (2006).
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between the median responses of the FA and
the 0.06-ppm exposures (or that the median
O3-induced decrement equals zero) is rejected
using the two-tailed sign test (p = 0.0019).
We also conducted alternative analyses of the
data using the Wilcoxon signed rank test and
the paired t-test. The null hypothesis of no
difference between responses for the FA and
0.06-ppm O3 exposures was rejected by both
tests (Table 2). Although the data had no
extreme outliers, we ﬂagged three responses as
potential outliers according to the Tukey cri-
teria. The characteristics of the data change
little with exclusion of the single most
extreme value (subject 23 in Table 1) or all
three potential outliers (subjects 10, 12, and
23 in Table 1) removed (Table 2).
Discussion
We have demonstrated that the FEV1 decre-
ments that occur after a 6.6-hr exposure to
0.06 ppm O3 are statistically different from
those that occur after FA exposure (p < 0.01).
We arrive at the same ﬁnding regardless of the
statistical test we employ or the approach to
treating potential outliers in the data. That
the effect of 0.06 ppm O3 on FEV1 occurred
not by chance alone is further supported by
two additional observations. First, the FA and
0.06-ppm responses in FEV1 generally track
each other for the first 4.6 hr of exposure,
with no evidence of wide swings in the data.
The responses clearly diverge for both the
5.6- and 6.6-hr data points, indicating that
the response at 6.6 hr is not a single anom-
alous data point (Figure 1). The group mean
O3-induced decrement at 5.6 hr (~ 2.4%) is
only marginally smaller than that at 6.6 hr
(2.85%). This temporal pattern of response is
generally consistent with patterns of response
after 0.08 ppm, 0.10 ppm, and 0.12 ppm in
numerous studies in which the O3 response
begins to diverge from the FA response at ear-
lier time points during exposure to higher
concentrations of O3 (Adams 2000, 2002,
2003; Folinsbee et al. 1988; Horstman et al.
1990). Second, the magnitude of the group
mean O3-induced response of this sample
after exposure to 0.08 ppm O3 is 6.07%,
which is quite consistent with observed
responses to 0.08-ppm exposure from other
studies (Figure 2), indicating that this sample
of volunteers is not unusually sensitive to O3.
We thus have no reason to suspect that the
observed average response at 0.06 ppm is
inflated because of attributes of the target
population or sampling error.
The existence of a small group mean
FEV1 decrement after a 6.6-hr exposure of
young exercising adults to 0.06 ppm should
not come as a surprise. Figure 2 presents
response data from studies that used an expo-
sure protocol nearly identical to that used by
Adams (2006). These studies all used young,
healthy adults as volunteers; exposure dura-
tion was for 6.6 hr, and exercise pattern and
VE (~20 L/min/m2 BSA) were similar. The
group mean FEV1 response to the 0.08-ppm
exposure for the Adams (2006) study is con-
sistent with other studies. Furthermore, the
observed FEV1 responses at 0.04 ppm O3
(Adams 2002) and 0.06 ppm O3 (Adams
2006) are almost identical to the response
predicted by a model based on data from 15
studies conducted at the U.S. EPA Human
Studies Facility in Chapel Hill, North
Carolina (McDonnell et al. 2007). The
smooth C–R curve illustrated in Figure 2 is
consistent with C–R curves for shorter-
duration (2 hr) exposures, which have typically
been observed to be smooth without obvious
discontinuities over a wide range of concentra-
tions, including those where effects were near
zero (Avol et al. 1984; Hazucha 1987; Kulle
et al. 1985; McDonnell et al. 1983).
The stark difference between our conclu-
sions and those of Adams (2006) with regard
to whether a 6.6-hr exposure to 0.06 ppm O3
induces statistically significant FEV1 decre-
ments requires further explanation. We have
identified three factors that we believe con-
tribute to the difference in conclusions. First,
no p-value is given in the original manuscript
for the comparison of the 6.6-hr FA and 0.06-
ppm responses. The group mean difference of
2.85% is simply reported as not being statisti-
cally significantly different from zero at α =
0.05 using the Scheffé test to correct for the
multiple comparisons. However, in Table 3 of
the original manuscript, the difference
between the 0.08-ppm and 0.06-ppm expo-
sures after 6.6 hr (3.21%) is reported as being
statistically different from zero. Because the
analysis of variance and the Scheffé method
used by Adams assume equal variances for all
means, it is reasonable to assume that the dif-
ference of 2.85% between 0.06 ppm and FA
approached statistical signiﬁcance—even with
this most conservative methodology.
A second factor causing differences in con-
clusions reached herein compared with those
of Adams (2006) results from differences in the
purpose of our reanalysis compared with the
purpose of the original study, the statistical
approaches used, and the approach to control-
ling for multiple statistical tests. The stated
purpose of the Adams (2006) study implies a
large number of comparisons among six expo-
sure protocols and seven time points (0, 1, 2,
3, 4.6, 5.6, and 6.6 hr). The Scheffé method
allows all pairwise comparisons as well as an
inﬁnite number of linear contrasts among the
cell means to be made while limiting the prob-
ability of making a single type 1 statistical error
among all the potential contrasts to 0.05.
Although there is nothing inherently wrong
with making a large number of contrasts and
strictly maintaining a studywide alpha level
using the Scheffé method, this approach comes
at the cost of reduced statistical power for
assessing differences for speciﬁc comparisons.
Setting aside all the theoretically possible linear
contrasts, there are 15 possible direct com-
parisons between the six protocols used by
Adams (2006) at the 6.6-hr time point. The
Bonferroni procedure would be the preferred
multiple comparison correction for this
Effect of 0.06 ppm ozone on lung function
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Table 2. Descriptive and inferential statistics for O3-induced decrementsa in FEV1 for the full data set
(n = 30) and for two data sets with potential outliers removed.
Data set
n = 30 n = 29 n = 27
Mediana 2.91% 2.81% 2.81%
Meana 2.85% 2.45% 2.44%
SEa 0.78% 0.69% 0.51%
95% conﬁdence intervala 1.26–4.45% 1.03–3.87% 1.38–3.49%
Sign test p-valueb 0.0019 0.0030 0.0021
Wilcoxon p-valueb,c 0.0008 0.0014 0.0004
Paired t-test p-valueb 0.0010 0.0014 <0.0001
aO3-induced decrements are the difference between percent decrements in FEV1 from the preexposure for the 0.06 ppm
O3 and FA exposures. bp-Values are two sided. cWilcoxon signed rank test. 
Figure 2. Cross-study comparison of mean
O3-induced FEV1 decrements due to 6.6 hr of con-
stant, S-W exposure to varied O3 concentrations. All
exposures were conducted in a chamber, except for
a face-mask exposure to 0.04 ppm O3 in the Adams
(2002) study. All studies used a 6.6-hr exposure pro-
tocol in which volunteers alternated between 50 min
of exercise (VE ≈ 20 L/min/m2 BSA) and 10 min of rest
with an additional 35 min of rest after the third hour.
For this exposure protocol, the McDonnell et al.
(2007) curve illustrates the predicted FEV1 decre-
ment at 6.6 hr as a function of O3 concentration for a
23-year-old. Error bars (where available) are the SE
of responses. The data at 0.08 and 0.12 ppm have
been offset for illustrative purposes.
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×relatively small number of comparisons
(Schwertman and Carter 1995). A critical
alpha for the possible comparisons between the
six protocols at the 6.6-hr time point would be
0.05 ÷ 15, or 0.0033. We compared only the
FEV1 responses at 6.6 hr between FA and
0.06-ppm O3 S-W exposure. Even with a cor-
rection for the additional comparisons, which
we did not consider, all of the tests presented
in Table 2 remain statistically signiﬁcant.
The third factor potentially contributing
to the disparity in our conclusions compared
with those of Adams (2006) involves errors
caused by data not meeting the criteria for the
statistical tests applied. The two-factor analysis
of variance and Scheffé method cited by
Adams (2006) assume that data are normally
distributed and that variances are equal within
cells. From previous studies of higher O3
exposures, we know that FEV1 responses
become skewed and that variance increases
(McDonnell 1996). This increase in variance
is clearly apparent in the Adams (2006) data,
with the standard deviation of FEV1 responses
increasing from 2.98% for FA to 4.24% for
0.06 ppm O3 to 8.65% at 0.08 ppm. It is pos-
sible that the wide range in variances among
the cells resulted in wider confidence levels
and inaccuracies of the reported p-values for a
subset of the comparisons.
Assuming for the moment that the O3-
induced decrement at 0.06 ppm is not zero and
that the best point estimate of the magnitude of
the mean decrement is 2.85% (95% conﬁdence
interval, 1.26–4.45%), what can we say about
the possible clinical significance of reversible
effects of such magnitude? It is unlikely that
individuals experiencing a 3% reduction in
FEV1 would be aware of such an effect, and
effects of this magnitude are at the outer range
of expected day-to-day variability of the mea-
surement. We know, however, that individuals
vary reproducibly in their responses to O3
exposure, and it is those most responsive indi-
viduals who are likely to experience clinically
significant effects. Although the average
response was small, two subjects in the Adams
(2006) study had > 10% FEV1 decrements
(12.8% and 14.5%). The U.S. EPA has consid-
ered any individual changes in FEV1 of
10–20% to be a moderate effect clearly outside
the range of normal within-day variability (U.S.
EPA 2006, 2007). In the Adams (2006) study,
2 of 30 individuals (i.e., 7%) experienced such
effects. This observed proportion of individuals
having a > 10% decrement in FEV1 at 0.06
ppm is consistent with a smooth C–R curve
that includes observed proportions from previ-
ous studies of 26% at 0.08 ppm, 41% at 0.10,
and 57% at 0.12 ppm [proportions calculated
for S-W exposures in U.S. EPA (2007),
Table 5-3]. If one converts the SD values to SE
values in Adams (2006, Table 4), the SEs for
the symptoms resulting from the 0.06-ppm
S-W exposure do not overlap those for the FA
exposure. This is suggestive of an effect of 0.06
ppm on respiratory symptoms as well as FEV1.
A reversible loss of lung function in combina-
tion with the presence of symptoms is consid-
ered adverse (American Thoracic Society 2000).
It thus appears that a small fraction of individu-
als exposed to 0.06 ppm O3 for 6.6 hr during
moderate exercise may approach a degree of
response that is considered to be adverse.
To meet the objectives of his study, Adams
(2006) required that a large number of com-
parisons be made and that comparisons not be
identiﬁed as statistically signiﬁcant by chance
alone. Appropriately, the Scheffé test was
employed to meet these needs. Although
Adams (2006) did not ﬁnd the FEV1 responses
of the 0.06 ppm O3 and FA exposures to be
statistically different, no measure of the proba-
bility of a type 2 statistical error was provided,
which would be required before drawing a
conclusion that a true difference does not exist.
The objective of the present study was to
reevaluate the lung function data of subjects
exposed for 6.6 hr to 0.06 ppm O3. Regardless
of the statistical test used, we found the post-
exposure FEV1 decrements for the FA and
0.06-ppm O3 exposures to be strongly signiﬁ-
cantly different. Complete resolution of this
question must necessarily await further studies
designed to address this speciﬁc question with
adequate statistical power. However, compari-
son with the results of other studies support
the interpretation that our ﬁnding is not due to
chance alone and, indeed, is consistent with a
smooth C–R curve.
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